Pharma Excipients

News on Pharma Excipients

Fabrication of polymeric sorafenib coated chitosan and fucoidan nanoparticles: Investigation of anticancer activity and apoptosis in colorectal cancer cells

The most prevalent form of colon cancer also ranks high among cancer-related deaths globally. Traditional chemotherapy drugs do not provide sufficient therapeutic efficacy, and advanced colon cancer demonstrates considerable resistance to chemotherapy. As an oral kinase inhibitor, sorafenib (SOR) suppresses the growth of tumour cells, the formation…

Skin-friendly textures – by Gattefossé

Caring for patients Patient preferences and needs as well as therapeutic indication should be considered at early stage of development of topical or transdermal formulations. To increase adherence to skin treatments, it is important…

Roquette signs agreement to acquire IFF Pharma Solutions

La Madeleine (France), 19 March 2024 – Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, announced today an agreement to acquire IFF Pharma Solutions, a worldwide producer of excipients for oral dosage…